Aryx Therapeutics I Financials
ARYXDelisted Stock | USD 0.0005 0.00 0.00% |
Aryx |
Understanding current and past Aryx Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aryx Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Aryx Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Aryx Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aryx Therapeutics I. Check Aryx Therapeutics' Beneish M Score to see the likelihood of Aryx Therapeutics' management manipulating its earnings.
Aryx Therapeutics Stock Summary
Aryx Therapeutics competes with Medicure, Ascend Wellness, Incannex Healthcare, Phibro Animal, and Supernus Pharmaceuticals. ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.Specialization | Healthcare, Biotechnology |
Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US0433871094 |
CUSIP | 043387109 |
Location | California; U.S.A |
Business Address | 6300 Dumbarton Circle, |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.aryx.com |
Phone | 510 585 2200 |
Currency | USD - US Dollar |
Aryx Therapeutics Key Financial Ratios
Aryx Therapeutics' financial ratios allow both analysts and investors to convert raw data from Aryx Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Aryx Therapeutics over time and compare it to other companies across industries.Return On Asset | -0.75 | ||||
Target Price | 1.5 | ||||
Number Of Employees | 56 | ||||
Beta | 0.0896 | ||||
Z Score | -24.3 |
Aryx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aryx Therapeutics's current stock value. Our valuation model uses many indicators to compare Aryx Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aryx Therapeutics competition to find correlations between indicators driving Aryx Therapeutics's intrinsic value. More Info.Aryx Therapeutics I is rated fifth in return on asset category among its peers. It also is rated fifth in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aryx Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aryx Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aryx Therapeutics Market Pulse
Quote | 5.0E-4 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 5.0E-4 |
Low | 5.0E-4 |
High | 5.0E-4 |
Volume | 0 |
Exchange | PINK |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Aryx Pink Sheet
If you are still planning to invest in Aryx Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aryx Therapeutics' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |